Share Name Share Symbol Market Type Share ISIN Share Description
Sphere Medical LSE:SPHR London Ordinary Share GB00B551W951 ORD 1P
  Price Change % Change Share Price Bid Price Offer Price High Price Low Price Open Price Shares Traded Last Trade
  +0.00p +0.00% 0.40p 0.35p 0.45p - - - 0 05:31:08
Industry Sector Turnover (m) Profit (m) EPS - Basic PE Ratio Market Cap (m)
Health Care Equipment & Services 0.0 -5.1 -3.2 - 0.57

Sphere Medical Share Discussion Threads

Showing 1776 to 1799 of 1800 messages
Chat Pages: 72  71  70  69  68  67  66  65  64  63  62  61  Older
DateSubjectAuthorDiscuss
15/7/2018
07:15
Take your point cellis.There might be a silver lining in that previous Management who made such a hash of running the Co could be sold on the idea that a new team could do a better job and have plenty of upside. Look at it this way had we still been in the public mrkts the stock would probably be c.2p as another funding round got the cold shoulder. Won't be long before £100m will have been spent on P for absolutely zero return. Must rank as one of the most catastrophic waste of monies on a product that nobody wants or cares about. A little bit of mrkt research would have told them that! We need a miracle or find the best salesman who ever lived to take us from 6 P's to 7 Ps sold assuming that's what were in business for and not spending another £10m on useless upgrades and management perks.
johnlewis79
14/7/2018
19:21
It's more than that John what have they been doing since P4 was shipped off to get approved! When was that June 2016 , R & D on what ? that's two years ago !!
cellis94
13/7/2018
09:38
DD...always been the case i'm afraid....as they are not interested in sales why would W etc invest and does anybody know what they have been doing since Sept'17?
johnlewis79
12/7/2018
10:45
Not sure it's dead yet, let's see if they can achieve one more funding round - I suspect the warrants may be the source of additional funding, but you'd have to be mad to invest more without evidence of solid interest/orders
dusseldorf
11/7/2018
16:32
All fell silent , not even the death throws of Sphere Medical registered a single decibel it's yet another case for Sherlock! "Medical mystery gone south "
cellis94
26/6/2018
07:36
NHS at 70....live on bbc2 tonight.A discussion on the failings as demand outstrips resources etc, etc... Or....spot the Proxima machine.
johnlewis79
21/6/2018
12:07
Next non update at year end...Will they make it? No more than an even money shot at best, having to rely on W aint wot i signed up for!
johnlewis79
21/6/2018
08:41
.....secondly look at the earnings needed to be admitted! Rules Sphere out!
johnlewis79
21/6/2018
08:39
.....solid history and top notch management required for nsdq listing for bloody starters! That rules out Sphere!
johnlewis79
21/6/2018
06:01
DD I doubt a Nsdq listing. The terms of entry are far too onerous and Sphere would have zero chance of qualifying. I can't remember the nos needed to list but Sphere will not have a cat in hells chance. You'd a thunk the Chairman would have issued an AGM statement but as I expected they got nowt to say.
johnlewis79
20/6/2018
14:04
We just have to be patient. I expect next update from the company will be that it's raised another £5-8m or that the plug is pulled. If they raise the funds, Woodford must have his eyes on a bigger prize e.g. Nasdaq listing.
dusseldorf
14/6/2018
11:24
Zilch...as expected.
johnlewis79
13/6/2018
05:32
Sphere AGM today. I shan't be attending so i hope a pis attends and gives us the low down on what they have been up to these last 9 months.
johnlewis79
08/6/2018
11:21
gnnmartin - I think at present, until we know the quantum of Woodfords investment (and price) it's not possible to ascertain any defined minimum for Preference A to be worth something, though we can best guess... Lets assume Woodford et al repeat funding at a similar price point 'fair value' after all 1 year later has fair value really changed? Arguably, they could end up with a bigger discount and more shares, but lets assume £5m gets them ~180m more shares. The £3m may be open for shareholders as per before, I doubt anyone would take it. This might give a total share issuance for Sphere medical Ltd of ~500,000,000. We also have outstanding warrants that could be converted into preference shares, which could again, skew this number a further 20% higher) if used as an alternative funding mechanism (286,676,115) £25m/500m = 5p/share? (or 4.25p ish if warrants mechanism used) for class A to have value (i..e offers over £25m) Seems reasonable I guess. If a Nasdaq/FTSE/AIM IPO is planned with £20m injection and a pre-money valuation of £80m then that would give 16p/share or 13.8pish if warrants mechanism used.
dusseldorf
08/6/2018
07:40
Or, and I haven't had time to read it properly is this a walk away agreement for Woodford. He gives the company to the management but gets some money back if it's ever successful?
cc2014
08/6/2018
07:23
As I said...it's a bust. Should it stagger on the ords will be wiped out. Thats what poor management does to investors aided and abetted by supine craven iis...who you notice have all bailed at huge losses. Woodford the last man standing on very shaky ground. I shudda twigged long ago that P is not wanted or required. Wedded as the NHS is to stone age practices, over-manning bureaucracy and under-manning of frontline staff P never stood a chance. Cudda,shudda, don't cut it anymore. What a waste of 10+ years.
johnlewis79
07/6/2018
20:20
I must have been on good form when I first looked at the proposed articles. I have found the bit that (roughly) confirms the ordinary get 16p per share before the new A shares get anything. It says: For the avoidance of doubt, in the event the proceeds on an A Share Qualifying Exit are equal or less than £25,000,000, then the holders of A Ordinary Shares shall not participate in any of the sale proceeds. I think £25,000,000 comes to 17p per ordinary share, hmmm I wonder where I got the 16p from then. Come to think of it, that doesn't take account of the preference shares. Oh well, I'll get back in my teapot.
gnnmartin
07/6/2018
18:29
This document is very odd. For a company that seems to have no cash and little future it must have cost a fortune to produce. Setting that aside, one must presume Woodford is going to put some more money in else why produce the document at all. As to whether it is skewed in his favour I have no idea.
cc2014
07/6/2018
09:19
It's had nearly two years in development since P4 was launched, that's two years they've been pulling the wool over Woodford's eyes ,the sale numbers have never stacked up ,2 took up P3 Germany and the Netherlands and 4 in the UK , talk of over 40 hospitals asking for data , 20 or so having demonstrations, and 3 months on from that , it's was still 6 , that was over a year ago , and the earth hasn't moved, I set my self target of 8 minimum which they couldn't hit , it was like expecting Englandto win a football match without boring us to death , if Woodford stumps up another penny he must have a screw missing let alone loose
cellis94
07/6/2018
00:49
Good grief, that document is the hardest read I've come across. I don;t really have the patience or jargon acumen to break it down. http://www.spheremedical.com/sites/default/files/Sphere%20New%20Articles%20(growth%20shares)%20FINAL.PDF gnnmartin - well done if you've actually managed to break it down to numbers, I couldn't find 16p explicitly stated. It would appear though that a number of possibilities are outlined. - Another £5-8m fundraise this year - A total sale valuation (offer) must be in excess of £20m for class A shares to be worth 'anything' - They are linking class A shares also to IPO's (e.g. Nasdaq/LSE Main/AIM) - A qualifying IPO is deemed to be a pre-money valuation of £80m with a minimum of £20m cash raised I'm not really sure what to make of it, but suggests Woodford is not done yet, and with Wales may well inject another £5-8m shortly, at what price, who knows. You wouldn't do it though unless you had your eyes on a bigger prize. The exit plan could then be either be to solicit offers (while cashed up) or go for an IPO with a minimum valuation of £100m. Given I own 3,000,000 (bought at the death of aim listing) I should really take more of an interest, but it feels it's way to early to bring this back from my current carry of £0.
dusseldorf
06/6/2018
12:06
16p...thats for the fairies...more like 0.016 This is a bust. I've moved on never want to hear about this bloody Co again.Circumstances kyboshed the stock which stupidly I ignored. An expensive lesson. Chers Rencken!
johnlewis79
05/6/2018
20:03
I don't have a copy of the proposal, and a Dusseldorf says, the web site is broken at the moment so I can't get hold of a copy. I made my post after calculating the 16p datum, but later found it explicitly stated. Try scanning for 16p, when you can get a copy of the proposal.
gnnmartin
05/6/2018
13:53
The website currently getting an internal 500 error, was going to take a look at the doc as I haven't seen it. Either the site has been hacked or a substantial update/rebrand underway. I'll have a look at the proposal, but I'm not convinced by the comment above re: 16p/share before class 'A' get anything, doesn't align with what's viable to incentivize employees. Right now that would not be an incentive and would be worthless, so I suspect something hidden away that aligns incentives at a much lower price. Could be wrong - but 16p given last funding seems wrong.
dusseldorf
04/6/2018
17:12
wpct May update...no mention of SM....why would they...sfa happening
johnlewis79
Chat Pages: 72  71  70  69  68  67  66  65  64  63  62  61  Older
Your Recent History
LSE
GKP
Gulf Keyst..
LSE
QPP
Quindell
FTSE
UKX
FTSE 100
LSE
IOF
Iofina
FX
GBPUSD
UK Sterlin..
Stocks you've viewed will appear in this box, letting you easily return to quotes you've seen previously.

Register now to create your own custom streaming stock watchlist.

By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions

P:41 V: D:20180717 00:24:06